跳至主要内容
临床试验/DRKS00031957
DRKS00031957招募中不适用

on-interventional, prospective study to evaluate the predictive potential of early CRP kinetics, in particular the CRP flare-response phenomenon, on the efficacy of immunotherapy in advanced urooncological tumors (renal cell carcinoma, urothelial carcinoma). Prospective Evaluation of the CRP-FLAre phenomenon on Immunotherapy REsponse in Urooncology (FLAIRE). - FLAIRE

Klinik und Poliklinik fu¨r Urologie und Kinderurologie Universitätsklinikum Bonn0 个研究点目标入组 200 人开始时间: 2023年6月1日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
200

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 Years 至 one(—)
性别
All

入选标准

  • Patients with histologically confirmed metastatic renal cell carcinoma or urothelial carcinoma who qualify for immune checkpoint inhibitor therapy (not adjuvant or maintenance therapy) as part of approved standard therapy
  • Informed written consent to participate in the FLAIRE study has been obtained

排除标准

  • Patient is unable to understand the scope, significance, and consequences of this clinical trial

研究者

发起方
Klinik und Poliklinik fu¨r Urologie und Kinderurologie Universitätsklinikum Bonn

相似试验

on-interventional, prospective study to evaluate the... | 临床试验